Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers
- 1 January 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 25 (1) , 78-82
- https://doi.org/10.1128/aac.25.1.78
Abstract
Cefuroxime axetil is a new orally absorbed prodrug of the antibiotic cefuroxime. The results of pharmacological studies in 52 healthy volunteers are presented. Intact cefuroxime axetil was not detected in the systemic circulation, indicating that deesterification to yield cefuroxime occurs rapidly after absorption. The bioavailability as measured by urinary recovery of cefuroxime was 40 to 50% if the drug was taken after food and 30% if the drug was taken after overnight fasting. Absorption was similar for three different formulations at 500 mg and independent of dose over the range of 250 mg to 1 g. When the drug was taken after food, serum levels and urinary recoveries were significantly greater for cefuroxime than for ampicillin, but when the drug was taken after fasting the values were similar for the two drugs. The kinetic behavior of cefuroxime axetil and ampicillin was not influenced by repeated dosing at 250 mg. Cefuroxime axetil was well tolerated. Although changes in bowel flora and habit were noted during repeated dosing, these changes were no greater than with ampicillin.This publication has 7 references indexed in Scilit:
- Antimicrobial usage in forty-three hospitals in EnglandJournal of Antimicrobial Chemotherapy, 1982
- Bioavailability and Metabolism of TalampicillinChemotherapy, 1978
- Undescribed toxin in pseudomembranous colitis.BMJ, 1977
- Bioavailability of Ampicillin and Amoxicillin in Fasted and Nonfasted SubjectsJournal of Pharmaceutical Sciences, 1977
- An introduction to mecillinamJournal of Antimicrobial Chemotherapy, 1977
- Cefuroxime: Human PharmacokineticsAntimicrobial Agents and Chemotherapy, 1976
- Gastrointestinal Absorption of DrugsMedical Clinics of North America, 1974